Mesa Verde Venture Partners
Mesa Verde Venture Partners focuses on investing in a diversified portfolio of early-stage biotechnology and medical technology companies.
Business Model:
Revenue: $3.8M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Mesa Verde Venture Partners Information
Geographic Data
Address: 2550 5th Ave
City: San Diego
State: CA
Zip: 92103
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$5M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Mesa Verde Venture Partners focuses on investing in a diversified portfolio of early-stage biotechnology and medical technology companies. Its areas of focus include drug discovery/tools, medical devices and diagnostics, and healthcare information technology. The company was founded in 2006 and headquartered in San Diego, California.
Contact Phone:
+16192897428
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2017 | Biscayne NeuroTherapeutics | Series B | 3M |
| 12/2019 | Immix Biopharma | Venture Round | - |
| 1/2017 | Biscayne Pharmaceuticals | Series B | 3M |
| 6/2019 | NeuraLace Medical | Seed Round | 0 |
| 9/2012 | Exagen | Series C | 5.3M |
| 5/2020 | CalciMedica | Series C | 15M |
| 8/2018 | Paradigm Diagnostics | Series B | 0 |
| 11/2011 | Lineagen | Series B | 0 |
| 1/2012 | Elevation Pharmaceuticals | Series B | 0 |
| 9/2011 | Elevation Pharmaceuticals | Series A | 0 |
| 1/2015 | Lineagen | Series C | 0 |
| 12/2013 | Lineagen | Series C | 0 |
| 5/2019 | Paradigm Diagnostics | Series B | 0 |
| 12/2008 | Lineagen | Series A | 5.8M |
| 4/2009 | Traversa Therapeutics | Series B | 5M |
| 6/2008 | Medipacs | Venture Round | 1.6M |
| 8/2010 | Lineagen | Series A | 10.8M |
| 2/2011 | Biomatrica | Venture Round | 1.2M |
| 1/2010 | Elevation Pharmaceuticals | Series A | 30M |
| 1/2019 | Immusoft | Series B | 0 |
| 9/2020 | Immusoft | Venture Round | 0 |
| 5/2011 | Exagen | Venture Round | 5.4M |
| 2/2011 | Exagen | Venture Round | 16.9M |
| 11/2013 | Exagen | Debt Financing | 25M |
| 9/2020 | Immusoft | Venture Round | 0 |
| 5/2020 | CalciMedica | Series C | 0 |
| 12/2019 | Immix Biopharma | Venture Round | - |
| 6/2019 | NeuraLace Medical | Seed Round | 0 |
| 5/2019 | Paradigm Diagnostics | Series B | 0 |
| 1/2019 | Immusoft | Series B | 0 |
| 8/2018 | Paradigm Diagnostics | Series B | 0 |
| 1/2017 | Biscayne Pharmaceuticals | Series B | 0 |
| 1/2017 | Biscayne NeuroTherapeutics | Series B | 0 |
| 1/2015 | Lineagen | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
